Criteo (NASDAQ:CRTO – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at Stifel Nicolaus in a research note issued to investors on Thursday,Benzinga reports. They currently ...

Lindsey Piegza, Stifel chief economist, joins 'Money Movers' to discuss Piegza's thoughts on Friday's jobs report, if the ...

The Digital Kina is the first central bank digital currency to be built on the open source Hyperledger Iroha 2 blockchain. The pilot was conducted by the Bank of Papua New Guine a in cooperation with ...

Stifel analysts maintained a Hold rating on NXP Semiconductors NV (NASDAQ:NXPI) with a steady price target of $231.00. The semiconductor company, currently valued at $51.28 billion, reported in-line ...

Q4 2024 Earnings Conference Call January 29, 2025 9:30 AM ETCompany ParticipantsJoel Jeffrey - Senior Vice President ...

Stifel Nicolaus’ price objective would suggest a potential upside of 8.50% from the company’s current price. TFII has been the subject of a number of other reports. Royal Bank of Canada ...

Stifel raised the firm’s price target on New Fortress Energy (NFE) to $23 from $17 and keeps a Buy rating on the shares. The firm notes that on Wednesday, New Fortress announced the 20-year ...

Thursday, January 23, 2025, marks the release of a new report by Stifel analysts on the US transport sector. The report outlines a cautious perspective on the industry's future, noting that while ...

This live page is now closed. You can continue to follow our coverage here.

Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...

Alpaca Real Estate (“ARE”), an alternative investment management firm, closed a $50 million credit facility with Stifel Bank. This financing marks another key milestone in the firm’s growth, ...